18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: A multicentre study
European Journal of Radiology, 11/14/2011Grassetto G et al.
18F–FDG–PET/CT may have a potential role in asymptomatic patients with rising markers and negative conventional imaging. The findings agree with other studies in promoting regular investigations such as tumor markers and 18F–FDG–PET/CT rather than awaiting the developments of physical symptoms as suggested by current guidelines since the timely detection of early recurrence may have a major impact on therapy and survival.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.